-
2941
Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens
Published 2024-12-01“…Safeguarding patients from emerging infectious diseases demands strategies that prioritise patient well-being and protection. …”
Get full text
Article -
2942
-
2943
-
2944
-
2945
A single residue switch mediates the broad neutralization of Rotaviruses
Published 2025-01-01Get full text
Article -
2946
-
2947
-
2948
Blimp-1 orchestrates macrophage polarization and metabolic homeostasis via purine biosynthesis in sepsis
Published 2025-02-01Get full text
Article -
2949
-
2950
-
2951
PCSK9: A Potential Therapeutic Target for Sepsis
Published 2020-01-01“…Proprotein convertase subtilisin/kexin type 9 (PCSK9) is often upregulated in the presence of sepsis and infectious diseases. In sepsis, PCSK9 degraded the low-density lipoprotein cholesterol (LDL) receptors (LDL-R) of the hepatocytes and the very low-density lipoprotein cholesterol receptors (VLDL-R) of the adipocytes, which then subsequently reduced pathogenic lipid uptake and clearance/sequestration. …”
Get full text
Article -
2952
A prognostic model of 8-T/B cell receptor-related signatures for hepatocellular carcinoma
Published 2025-01-01Get full text
Article -
2953
Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats
Published 2017-01-01Get full text
Article -
2954
-
2955
-
2956
A call to invest in post-TB lung disease to halt TB transmission in communities
Published 2024-02-01Get full text
Article -
2957
Purpurin suppresses Salmonella invasion of host cells by reducing the secretion of T3SS-1 effector proteins
Published 2025-02-01Get full text
Article -
2958
-
2959
Increased Incidence of Rhinovirus Pneumonia in Children During the COVID-19 Pandemic in Mexico
Published 2024-01-01Get full text
Article -
2960